848591-80-0 Usage
Uses
Used in Organic Synthesis:
Tert-butyl 3,8-diazabicyclo[4.2.0]octane-8-carboxylate is used as a chiral catalyst in organic synthesis for its ability to influence the reactivity and selectivity of reactions, leading to the formation of enantioselective products.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, tert-butyl 3,8-diazabicyclo[4.2.0]octane-8-carboxylate is used as a building block for the synthesis of more complex molecules, potentially contributing to the development of new pharmaceuticals.
Used in Prodrug Development:
Tert-butyl 3,8-diazabicyclo[4.2.0]octane-8-carboxylate is used as a prodrug in pharmaceutical formulations, allowing for the controlled release of the active molecule in a biological system, which can improve the drug's efficacy and reduce side effects.
Used in Chemical Research:
tert-butyl 3,8-diazabicyclo[4.2.0]octane-8-carboxylate is also utilized in chemical research for studying the effects of bulky substituents on the reactivity and selectivity of catalysts, contributing to the advancement of synthetic methodologies and the understanding of reaction mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 848591-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,5,9 and 1 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 848591-80:
(8*8)+(7*4)+(6*8)+(5*5)+(4*9)+(3*1)+(2*8)+(1*0)=220
220 % 10 = 0
So 848591-80-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H20N2O2/c1-11(2,3)15-10(14)13-7-8-4-5-12-6-9(8)13/h8-9,12H,4-7H2,1-3H3
848591-80-0Relevant academic research and scientific papers
Substituted diazabicycloakane derivatives
-
Page/Page column 21, (2010/02/11)
Compounds of formula (I) Z-Ar1—Ar2??(I) wherein Z is a diazabicyclic amine, Ar1 is a 5- or 6-membered aromatic ring, and Ar2 is selected from an unsubstituted or substituted 5-membered heteroaryl ring; an unsubstituted or substituted 6-membered heteroaryl ring; 3,4-(methylenedioxy)phenyl; and phenyl substituted with 0, 1, 2, or 3 substituents in the meta- or para-positions. The compounds are useful in treating conditions or disorders prevented by or ameliorated by α7 nAChR ligands. Also disclosed are pharmaceutical compositions comprising compounds of formula (I) and methods for using such compounds and compositions.
